ArticleInternational journal of molecular sciences2022

A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes.

Kanut Laoharawee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.